AUTOLOGOUS STEM CELL TRANSPLANTATION VERSUS BORTEZOMIB-MELPHALAN-PREDNISONE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: FINAL ANALYSIS OF THE PHASE 3 EMN02/HO95 STUDY
AUTOLOGOUS STEM CELL TRANSPLANTATION VERSUS BORTEZOMIB-MELPHALAN-PREDNISONE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: FINAL ANALYSIS OF THE PHASE 3 EMN02/HO95 STUDY
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2019
Συγγραφείς:
Pantani, L Hajek, R Gay, F Beksac, M Dozza, L Johnsen, HE Petrucci, MT Mellqvist, UH Conticello, C Driessen, C others
